Abstract
The treatment of acute leukemia is usually similar in women and men. The outcome is also generally the same. However, diagnosis in women poses additional challenges in clinical practice such as leukemia following breast or ovarian cancers, prevention of abnormal uterine bleeding in premenopausal females, treatment during pregnancy related-problems in long-term survivors. All these special issues are addressed in this review of the literature.
MeSH terms
-
Acute Disease
-
Antineoplastic Agents / adverse effects
-
Breast Neoplasms / therapy
-
Female
-
Fertility / drug effects
-
Fertility / radiation effects
-
Humans
-
Leukemia, Myeloid, Acute / drug therapy*
-
Leukemia, Myeloid, Acute / etiology
-
Neoplasms, Second Primary / drug therapy*
-
Ovarian Neoplasms / therapy
-
Ovary / drug effects
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / etiology
-
Pregnancy
-
Pregnancy Complications, Neoplastic / etiology
-
Pregnancy Complications, Neoplastic / therapy
-
Puberty, Delayed / chemically induced
-
Sex Factors
-
Uterine Neoplasms / therapy